flag flag  

Radiological tumor size decrease at week 6 is a potent predictor of outcome in chemorefractory metastatic colorectal cancer treated with cetuximab (BOND trial).

Description : BACKGROUND: Early radiological tumor shrinkage may be associated with better long-term outcome in chemorefractory metastatic colorectal cancer (cmCRC) treated with cetuximab. We aimed at validating this in a large and independent series. PATIENTS AND METHODS: Of the 329 patients, 289 had a measureme...
Language(s) : English
Subject(s) : Treatment Outcome , Regression Analysis , Multivariate Analysis , Humans , Disease-Free Survival , Colorectal Neoplasms , Camptothecin , Antineoplastic Combined Chemotherapy Protocols , Antineoplastic Agents , Antibodies, Monoclonal
Publisher(s) :
Contributor(s) : UCL - MD/MINT - Département de médecine interne , UCL - AGRO/CABI - Département de chimie appliquée et des bio-industries
Source(s) :
Publication Date(s) : 2009-01-01